227 related articles for article (PubMed ID: 14640254)
21. [Coronary artery disease and menopausal hormone therapy].
Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
[No Abstract] [Full Text] [Related]
22. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
23. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
24. Heart disease in women.
Giardina EG
Int J Fertil Womens Med; 2000; 45(6):350-7. PubMed ID: 11140544
[TBL] [Abstract][Full Text] [Related]
25. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
26. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
27. [Role of hormone-replacement therapy for prevention of coronary artery disease in women].
Gohlke-Bärwolf C; von Schacky C
Z Kardiol; 2005; 94 Suppl 3():III/74-8. PubMed ID: 16258796
[TBL] [Abstract][Full Text] [Related]
28. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
Haskell SG
J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy, heart disease, and other considerations.
Barrett-Connor E; Grady D
Annu Rev Public Health; 1998; 19():55-72. PubMed ID: 9611612
[TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force recommendation statement.
Kreatsoulas C; Anand SS
Pol Arch Med Wewn; 2013; 123(3):112-7. PubMed ID: 23396275
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy in postmenopausal women.
Prelevic GM; Kocjan T; Markou A
Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
[TBL] [Abstract][Full Text] [Related]
32. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
33. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
34. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
Rossouw JE
Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [
